The research team projects that the Poliovirus Vaccine Inactivated market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Sanofi
IMBCA
GSK
Serum Institute (Bilthoven Biologicals)
By Type
Human Diploid Cell
Monkey Kidney Cell
By Application
Public
Private
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
Russia
Spain
Netherlands
Switzerland
Poland
South Asia
India
Pakistan
Bangladesh
Southeast Asia
Indonesia
Thailand
Singapore
Malaysia
Philippines
Vietnam
Myanmar
Middle East
Turkey
Saudi Arabia
Iran
United Arab Emirates
Israel
Iraq
Qatar
Kuwait
Oman
Africa
Nigeria
South Africa
Egypt
Algeria
Morocoo
Oceania
Australia
New Zealand
South America
Brazil
Argentina
Colombia
Chile
Venezuela
Peru
Puerto Rico
Ecuador
Rest of the World
Kazakhstan
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Poliovirus Vaccine Inactivated 2016-2021, and development forecast 2022-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2021 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2022-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Poliovirus Vaccine Inactivated Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).
Markat Analysis by Application Type: Based on the Poliovirus Vaccine Inactivated Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Poliovirus Vaccine Inactivated market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Poliovirus Vaccine Inactivated Market Size Analysis from 2022 to 2027
1.5.1 Global Poliovirus Vaccine Inactivated Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Poliovirus Vaccine Inactivated Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Poliovirus Vaccine Inactivated Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Poliovirus Vaccine Inactivated Industry Impact
Chapter 2 Global Poliovirus Vaccine Inactivated Competition by Types, Applications, and Top Regions and Countries
2.1 Global Poliovirus Vaccine Inactivated (Volume and Value) by Type
2.1.1 Global Poliovirus Vaccine Inactivated Consumption and Market Share by Type (2016-2021)
2.1.2 Global Poliovirus Vaccine Inactivated Revenue and Market Share by Type (2016-2021)
2.2 Global Poliovirus Vaccine Inactivated (Volume and Value) by Application
2.2.1 Global Poliovirus Vaccine Inactivated Consumption and Market Share by Application (2016-2021)
2.2.2 Global Poliovirus Vaccine Inactivated Revenue and Market Share by Application (2016-2021)
2.3 Global Poliovirus Vaccine Inactivated (Volume and Value) by Regions
2.3.1 Global Poliovirus Vaccine Inactivated Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Poliovirus Vaccine Inactivated Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Poliovirus Vaccine Inactivated Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Poliovirus Vaccine Inactivated Consumption by Regions (2016-2021)
4.2 North America Poliovirus Vaccine Inactivated Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Poliovirus Vaccine Inactivated Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Poliovirus Vaccine Inactivated Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Poliovirus Vaccine Inactivated Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Poliovirus Vaccine Inactivated Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Poliovirus Vaccine Inactivated Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Poliovirus Vaccine Inactivated Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Poliovirus Vaccine Inactivated Sales, Consumption, Export, Import (2016-2021)
4.10 South America Poliovirus Vaccine Inactivated Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Poliovirus Vaccine Inactivated Market Analysis
5.1 North America Poliovirus Vaccine Inactivated Consumption and Value Analysis
5.1.1 North America Poliovirus Vaccine Inactivated Market Under COVID-19
5.2 North America Poliovirus Vaccine Inactivated Consumption Volume by Types
5.3 North America Poliovirus Vaccine Inactivated Consumption Structure by Application
5.4 North America Poliovirus Vaccine Inactivated Consumption by Top Countries
5.4.1 United States Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
5.4.2 Canada Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
5.4.3 Mexico Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
Chapter 6 East Asia Poliovirus Vaccine Inactivated Market Analysis
6.1 East Asia Poliovirus Vaccine Inactivated Consumption and Value Analysis
6.1.1 East Asia Poliovirus Vaccine Inactivated Market Under COVID-19
6.2 East Asia Poliovirus Vaccine Inactivated Consumption Volume by Types
6.3 East Asia Poliovirus Vaccine Inactivated Consumption Structure by Application
6.4 East Asia Poliovirus Vaccine Inactivated Consumption by Top Countries
6.4.1 China Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
6.4.2 Japan Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
6.4.3 South Korea Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
Chapter 7 Europe Poliovirus Vaccine Inactivated Market Analysis
7.1 Europe Poliovirus Vaccine Inactivated Consumption and Value Analysis
7.1.1 Europe Poliovirus Vaccine Inactivated Market Under COVID-19
7.2 Europe Poliovirus Vaccine Inactivated Consumption Volume by Types
7.3 Europe Poliovirus Vaccine Inactivated Consumption Structure by Application
7.4 Europe Poliovirus Vaccine Inactivated Consumption by Top Countries
7.4.1 Germany Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
7.4.2 UK Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
7.4.3 France Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
7.4.4 Italy Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
7.4.5 Russia Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
7.4.6 Spain Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
7.4.7 Netherlands Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
7.4.8 Switzerland Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
7.4.9 Poland Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
Chapter 8 South Asia Poliovirus Vaccine Inactivated Market Analysis
8.1 South Asia Poliovirus Vaccine Inactivated Consumption and Value Analysis
8.1.1 South Asia Poliovirus Vaccine Inactivated Market Under COVID-19
8.2 South Asia Poliovirus Vaccine Inactivated Consumption Volume by Types
8.3 South Asia Poliovirus Vaccine Inactivated Consumption Structure by Application
8.4 South Asia Poliovirus Vaccine Inactivated Consumption by Top Countries
8.4.1 India Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
8.4.2 Pakistan Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Poliovirus Vaccine Inactivated Market Analysis
9.1 Southeast Asia Poliovirus Vaccine Inactivated Consumption and Value Analysis
9.1.1 Southeast Asia Poliovirus Vaccine Inactivated Market Under COVID-19
9.2 Southeast Asia Poliovirus Vaccine Inactivated Consumption Volume by Types
9.3 Southeast Asia Poliovirus Vaccine Inactivated Consumption Structure by Application
9.4 Southeast Asia Poliovirus Vaccine Inactivated Consumption by Top Countries
9.4.1 Indonesia Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
9.4.2 Thailand Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
9.4.3 Singapore Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
9.4.4 Malaysia Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
9.4.5 Philippines Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
9.4.6 Vietnam Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
9.4.7 Myanmar Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
Chapter 10 Middle East Poliovirus Vaccine Inactivated Market Analysis
10.1 Middle East Poliovirus Vaccine Inactivated Consumption and Value Analysis
10.1.1 Middle East Poliovirus Vaccine Inactivated Market Under COVID-19
10.2 Middle East Poliovirus Vaccine Inactivated Consumption Volume by Types
10.3 Middle East Poliovirus Vaccine Inactivated Consumption Structure by Application
10.4 Middle East Poliovirus Vaccine Inactivated Consumption by Top Countries
10.4.1 Turkey Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
10.4.3 Iran Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
10.4.5 Israel Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
10.4.6 Iraq Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
10.4.7 Qatar Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
10.4.8 Kuwait Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
10.4.9 Oman Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
Chapter 11 Africa Poliovirus Vaccine Inactivated Market Analysis
11.1 Africa Poliovirus Vaccine Inactivated Consumption and Value Analysis
11.1.1 Africa Poliovirus Vaccine Inactivated Market Under COVID-19
11.2 Africa Poliovirus Vaccine Inactivated Consumption Volume by Types
11.3 Africa Poliovirus Vaccine Inactivated Consumption Structure by Application
11.4 Africa Poliovirus Vaccine Inactivated Consumption by Top Countries
11.4.1 Nigeria Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
11.4.2 South Africa Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
11.4.3 Egypt Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
11.4.4 Algeria Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
11.4.5 Morocco Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
Chapter 12 Oceania Poliovirus Vaccine Inactivated Market Analysis
12.1 Oceania Poliovirus Vaccine Inactivated Consumption and Value Analysis
12.2 Oceania Poliovirus Vaccine Inactivated Consumption Volume by Types
12.3 Oceania Poliovirus Vaccine Inactivated Consumption Structure by Application
12.4 Oceania Poliovirus Vaccine Inactivated Consumption by Top Countries
12.4.1 Australia Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
12.4.2 New Zealand Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
Chapter 13 South America Poliovirus Vaccine Inactivated Market Analysis
13.1 South America Poliovirus Vaccine Inactivated Consumption and Value Analysis
13.1.1 South America Poliovirus Vaccine Inactivated Market Under COVID-19
13.2 South America Poliovirus Vaccine Inactivated Consumption Volume by Types
13.3 South America Poliovirus Vaccine Inactivated Consumption Structure by Application
13.4 South America Poliovirus Vaccine Inactivated Consumption Volume by Major Countries
13.4.1 Brazil Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
13.4.2 Argentina Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
13.4.3 Columbia Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
13.4.4 Chile Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
13.4.5 Venezuela Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
13.4.6 Peru Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
13.4.8 Ecuador Poliovirus Vaccine Inactivated Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Poliovirus Vaccine Inactivated Business
14.1 Sanofi
14.1.1 Sanofi Company Profile
14.1.2 Sanofi Poliovirus Vaccine Inactivated Product Specification
14.1.3 Sanofi Poliovirus Vaccine Inactivated Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 IMBCA
14.2.1 IMBCA Company Profile
14.2.2 IMBCA Poliovirus Vaccine Inactivated Product Specification
14.2.3 IMBCA Poliovirus Vaccine Inactivated Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 GSK
14.3.1 GSK Company Profile
14.3.2 GSK Poliovirus Vaccine Inactivated Product Specification
14.3.3 GSK Poliovirus Vaccine Inactivated Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Serum Institute (Bilthoven Biologicals)
14.4.1 Serum Institute (Bilthoven Biologicals) Company Profile
14.4.2 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Product Specification
14.4.3 Serum Institute (Bilthoven Biologicals) Poliovirus Vaccine Inactivated Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Poliovirus Vaccine Inactivated Market Forecast (2022-2027)
15.1 Global Poliovirus Vaccine Inactivated Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Poliovirus Vaccine Inactivated Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Poliovirus Vaccine Inactivated Value and Growth Rate Forecast (2022-2027)
15.2 Global Poliovirus Vaccine Inactivated Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Poliovirus Vaccine Inactivated Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Poliovirus Vaccine Inactivated Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Poliovirus Vaccine Inactivated Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Poliovirus Vaccine Inactivated Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Poliovirus Vaccine Inactivated Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Poliovirus Vaccine Inactivated Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Poliovirus Vaccine Inactivated Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Poliovirus Vaccine Inactivated Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Poliovirus Vaccine Inactivated Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Poliovirus Vaccine Inactivated Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Poliovirus Vaccine Inactivated Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Poliovirus Vaccine Inactivated Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Poliovirus Vaccine Inactivated Consumption Forecast by Type (2022-2027)
15.3.2 Global Poliovirus Vaccine Inactivated Revenue Forecast by Type (2022-2027)
15.3.3 Global Poliovirus Vaccine Inactivated Price Forecast by Type (2022-2027)
15.4 Global Poliovirus Vaccine Inactivated Consumption Volume Forecast by Application (2022-2027)
15.5 Poliovirus Vaccine Inactivated Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
The mRNA Vaccine Drugs Development Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The Human Rabies Vaccine Antibody Testing Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive ...
The Smart Vaccine Scenario-based Solution Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
The Pet Rabies Vaccine Antibody Testing Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive la...
The Rabies Vaccine Antibody Testing Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The Liquid Vaccine Filling Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...
The Pharmaceutical Vaccine Refrigerators Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
The White Oil for Vaccine Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers...
Executive Summary
Azoth Analytics has released a research report titled "Global Cold Chain Equipment Market (2024 Edition)" which provides a complete analysis of the Global Cold Chain Equipment market in terms of market segmentation By Equipment Type (Refrigerators, Deep Freezers & Reef...
Overview of the Global Vaccine Supply Chain Solutions Market:
The report discusses everything a marketer requires before investing in the global Vaccine Supply Chain Solutions Market during the forecast period 2023-...